BioCentury
ARTICLE | Emerging Company Profile

CG Therapeutics: Hormone neutralizer

March 10, 2008 7:00 AM UTC

While most cancer vaccines aim to stimulate the immune system to boost T cell production, CG Therapeutics Inc. believes that generating an antibody response will provide better efficacy against cancer targets.

CG is developing antibody-based immunotherapies, including vaccines, targeting human chorionic gonadotropin (hCG), a hormone that is a key to promoting the progression of solid tumors based on its angiogenic properties and ability to shield cells from the immune system. ...